In HNSCC, it was demonstrated that hsa-miR-206 plays a critical role progression by targeting HDAC6 via PTEN/AKT/mTOR pathway, which might be a potential target for diagnostic and therapeutic (Vickers et al., 2012). This evidence concerns the gene HDAC6 and head and neck squamous cell carcinoma.